OverviewChartNewsTraderScreen

Enzon Pharmaceuticals, Inc./  US2939041081  /

Nasdaq Other OTC
2024-09-04  9:54:36 PM Chg. +0.0035 Volume Bid- Ask- High Low
0.1525USD +2.35% 45,300
Turnover: 6,984.9950		 -Bid Size: - -Ask Size: - 0.1550 0.1525
GlobeNewswire 2022-01-24 OTC Markets Group Announces the 2022 OTCQX Best 50
GlobeNewswire 2021-01-06 Silence Therapeutics Appoints Craig Tooman as Chief Financial Officer  
GlobeNewswire 2021-01-04 Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assu...
GlobeNewswire 2020-10-21 Enzon Pharmaceuticals Announces Results of Rights Offering
GlobeNewswire 2020-09-15 Enzon Pharmaceuticals Announces Key Dates for Rights Offering
GlobeNewswire 2020-09-02 Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting
GlobeNewswire 2020-08-21 Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
GlobeNewswire 2020-08-14 Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shar...
GlobeNewswire 2020-01-07 Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operat...
GlobeNewswire 2019-12-12 Translate Bio Announces Executive Leadership Appointments
GlobeNewswire 2019-11-01 Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts E...
GlobeNewswire 2019-09-12 Investigation Report on China's Pegaspargase Market, 2019-2023
GlobeNewswire 2019-06-24 CureVac Welcomes Two Members to its Supervisory Board
GlobeNewswire 2019-03-18 Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Mor...
GlobeNewswire 2018-07-03 Cancer Therapies: World Industry Analysis & Forecasts to 2030 - Key Company Profiles, Emerging Techn...
GlobeNewswire 2018-04-20 Global Malignant Melanoma Drug Market Report 2018: Dosage, Price & Clinical Pipeline Outlook 2024
GlobeNewswire 2007-02-20 Notice of AGM